The safety of sublingual immunotherapy with one or more allergens in adults

Allergy. 2008 Mar;63(3):375-6. doi: 10.1111/j.1398-9995.2007.01608.x.

Authors

C Lombardi¹, S Gargioni, M Cottini, G W Canonica, G Passalacqua

Affiliation

¹ Allergy & Respiratory Diseases, Department of Internal Medicine, Padiglione Maragliano, L.go R. Benzi 10, 16132 Genoa, Italy.

PMID: 18269680
DOI: 10.1111/j.1398-9995.2007.01608.x

No abstract available

MeSH terms

Administration, Sublingual
Adolescent
Adult
Adverse Drug Reaction Reporting Systems
Allergens / immunology*
Cohort Studies
Desensitization, Immunologic / methods
Drug-Related Side Effects and Adverse Reactions
Female
Follow-Up Studies
Humans
Hypersensitivity / diagnosis*
Hypersensitivity / drug therapy*
Immunosuppressive Agents / administration & dosage
Immunosuppressive Agents / adverse effects*
Immunotherapy / adverse effects
Immunotherapy / methods
Italy
Male
Middle Aged
Product Surveillance, Postmarketing
Severity of Illness Index
Skin Tests

Substances

Allergens
Immunosuppressive Agents